Stock ALEXANDRIA PHARMA. & CHEMICAL INDUSTRIES
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Alexandria Pharma. & Chemical Industries Egyptian Exchange

Equities

Pharmaceuticals

End-of-day quote Egyptian Exchange
Other stock markets
- EGP - Intraday chart for Alexandria Pharma. & Chemical Industries
2023 Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
2022 Alexandria Co. For Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022 CI

Business Summary

Alexandria Co. for Pharmaceuticals & Chemical Industries SAE specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, dermatological, cardiovascular, allergic, epileptic, gastrointestinal diseases, etc. The group also provides veterinary and medical products (adhesive tape, gauze compresses, gloves, traction kits, etc.).

Sales per Business

EGP in Million2019Weight2020Weight Delta
Finished Goods
99.0 %
821 99.0 % 1,014 99.0 % +23.52%
Other Operating Income
1.0 %
8 1.0 % 10 1.0 % +23.86%

Sales per region

EGP in Million2019Weight2020Weight Delta
Egypt
100.0 %
829 100.0 % 1,024 100.0 % +23.52%

Managers

Managers TitleAgeSince
Abla Youssef Abdullah CEO
 Chief Executive Officer - -
Mohammed Noman Salamah DFI
 Director of Finance/CFO - -
Ahmed Fuad ADM
 Chief Administrative Officer - -
Sherif Salah Mohammed Tahoun BRD
 Director/Board Member - -
Magdy Fathallah PRN
 Corporate Officer/Principal - -
Mohammed Abdel Karim SAM
 Sales & Marketing - -

Members of the board

Members of the board TitleAgeSince
Mustafa Abdel Monem El-Hayawan CHM
 Chairman - -
Sherif Salah Mohammed Tahoun BRD
 Director/Board Member - -
Abla Youssef Abdullah CEO
 Chief Executive Officer - -
Ahmed Farouq Mahmoud Al-Dasouqi BRD
 Director/Board Member - -
Khamis Abdel Wahab Abdel Aal BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,000,000 981,182 ( 19.62 %) 0 19.62 %

Shareholders

NameEquities%Valuation
Concord International Investments LP
0.3372 %
16,859 0.3372 % 82 552 £

Company contact information

Alexandria Pharmaceuticals

Gamila Bohreid Road Awayed

21938, Alexandria

+

address Alexandria Pharma. & Chemical Industries

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AXPH Stock
  4. Stock
  5. Company Alexandria Pharma. & Chemical Industries